isoxazoles has been researched along with lithocholic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, A; Cui, J; Huang, L; Lo, JL; Meinke, PT; Metzger, E; Wright, SD; Yu, J; Zhao, A | 1 |
| Castelli, R; Giorgio, C; Hassan-Mohamed, I; Incerti, M; Lodola, A; Pala, D; Russo, S; Tognolini, M | 1 |
| Cui, S; Dai, H; Ge, Y; He, H; Jin, J; Shi, Y; Ye, F | 1 |
3 other study(ies) available for isoxazoles and lithocholic acid
| Article | Year |
|---|---|
Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Cloning, Molecular; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Escherichia coli; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Isoxazoles; Lithocholic Acid; Mixed Function Oxygenases; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Rifampin; RNA, Messenger; Transcription Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2002 |
Target hopping as a useful tool for the identification of novel EphA2 protein-protein antagonists.
Topics: Binding Sites; Cell Line, Tumor; Drug Design; Ephrin-A1; Humans; Isoxazoles; Lithocholic Acid; Molecular Docking Simulation; Protein Binding; Protein Interaction Maps; Protein Structure, Tertiary; Receptor, EphA2; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2014 |
Design, Synthesis and Biological Evaluation of Stilbene Derivatives as Novel Inhibitors of Protein Tyrosine Phosphatase 1B.
Topics: Drug Design; Enzyme Inhibitors; Inhibitory Concentration 50; Isoxazoles; Lithocholic Acid; Mass Spectrometry; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proton Magnetic Resonance Spectroscopy; Stilbenes; Structure-Activity Relationship | 2016 |